<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03700710</url>
  </required_header>
  <id_info>
    <org_study_id>2018-0433</org_study_id>
    <nct_id>NCT03700710</nct_id>
  </id_info>
  <brief_title>Remote Dietary Counseling to Promote Healthy Diet and Blood Pressure</brief_title>
  <official_title>Remote Dietary Counseling Using Web-based Tools to Promote Healthy Diet and Blood Pressure (Healthy BP)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Geisinger Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Geisinger Clinic</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      American College of Cardiology/American Heart Association (ACC/AHA) hypertension guidelines&#xD;
      recommend lifestyle modification for patients with elevated blood pressure. While eating a&#xD;
      Dietary Approaches to Stop Hypertension (DASH)-type diet, increasing physical activity, and&#xD;
      weight loss have been shown to reduce blood pressure, limited resources are available in the&#xD;
      primary care setting to help patients make these changes.&#xD;
&#xD;
      In this study, the investigators will compare the efficacy of a self-guided vs. dietitian-led&#xD;
      approach using web-based lifestyle modification tools to reduce weight, improve dietary&#xD;
      quality, and lower blood pressure in overweight/obese adults with elevated blood pressure.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Goals that all participants will be instructed to target include: 1) weight loss &gt;=3% at 3&#xD;
      months; 2) consume a healthier dietary pattern (high in fruits, vegetables, whole grains,&#xD;
      low-fat dairy, vegetable/fish/poultry sources of protein, healthier sources of fat, and avoid&#xD;
      sugar and salt); 3) reduce sodium intake to &lt;2300 mg/d; 4) at least 180 min/wk of&#xD;
      moderate-intensity physical activity.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 16, 2019</start_date>
  <completion_date type="Actual">June 30, 2021</completion_date>
  <primary_completion_date type="Actual">June 30, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in 24-hour Systolic Blood Pressure</measure>
    <time_frame>Baseline to 12-week follow-up</time_frame>
    <description>Measured by 24-hour ambulatory blood pressure monitoring (SpaceLabs Ontrak)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in 24-hour diastolic blood pressure</measure>
    <time_frame>Baseline to 12-week follow-up</time_frame>
    <description>Measured by 24-hour ambulatory blood pressure monitoring (SpaceLabs Ontrak)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Daytime Systolic Blood Pressure</measure>
    <time_frame>Baseline to 12-week follow-up</time_frame>
    <description>Measured by 24-hour ambulatory blood pressure monitoring (SpaceLabs Ontrak)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Nighttime Systolic Blood Pressure</measure>
    <time_frame>Baseline to 12-week follow-up</time_frame>
    <description>Measured by 24-hour ambulatory blood pressure monitoring (SpaceLabs Ontrak)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Daytime Diastolic Blood Pressure</measure>
    <time_frame>Baseline to 12-week follow-up</time_frame>
    <description>Measured by 24-hour ambulatory blood pressure monitoring (SpaceLabs Ontrak)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Nighttime Diastolic Blood Pressure</measure>
    <time_frame>Baseline to 12-week follow-up</time_frame>
    <description>Measured by 24-hour ambulatory blood pressure monitoring (SpaceLabs Ontrak)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Total Healthy Eating Index - 2015 score</measure>
    <time_frame>Baseline to 12-week follow-up</time_frame>
    <description>Assessed by Viocare Food Frequency Questionnaire (score 0-100, 100=best possible score)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Weight</measure>
    <time_frame>Baseline to 12-week follow-up</time_frame>
    <description>Weight measured at baseline and 12-week visits without shoes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Waist Circumference</measure>
    <time_frame>Baseline to 12-week follow-up</time_frame>
    <description>Measured using a tape measure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Physical Activity (metabolic equivalent of task [MET]-minute per week</measure>
    <time_frame>Baseline to 12-week follow-up</time_frame>
    <description>Measured by International Physical Activity Questionnaire (IPAQ) Short Form</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Change in individual components of Healthy Eating Index score</measure>
    <time_frame>Baseline to 12-week follow-up</time_frame>
    <description>Each individual component of the Healthy Eating Index score will be examined</description>
  </other_outcome>
  <other_outcome>
    <measure>Satisfaction with the Healthy BP Research Study</measure>
    <time_frame>12-week follow-up</time_frame>
    <description>5-point Likert score</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">187</enrollment>
  <condition>Blood Pressure</condition>
  <condition>High Blood Pressure</condition>
  <condition>Dietary Modification</condition>
  <condition>Overweight and Obesity</condition>
  <arm_group>
    <arm_group_label>Self-Guided Approach</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>In the self-guided arm, participants will receive access to web-based tools to help achieve healthy lifestyle changes to lower their blood pressure.&#xD;
The web-based tools include: 1) a web-based food frequency questionnaire (Viocare FFQ), which will provide a snapshot of participants' dietary habits in the past 6 months as well as personalized recommendations for areas to improve; 2) access to an evidence-based program (Evolve, formerly BMIQ), which includes program materials for weight loss and leading a healthy lifestyle as well as the ability for capturing dietary data entry.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Dietitian-led Approach</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>In the dietitian-led arm, dietitian will use motivational interviewing in 15-30 minute telephone calls with participants.&#xD;
The web-based tools include: 1) a web-based food frequency questionnaire (Viocare FFQ), which will provide a snapshot of participants' dietary habits in the past 6 months as well as personalized recommendations for areas to improve; 2) access to an evidence-based program (Evolve, formerly BMIQ), which includes program materials for weight loss and leading a healthy lifestyle as well as the ability for capturing dietary data entry.&#xD;
The web platform will be used to share participant dietary and weight data with dietitians.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Self-Guided Approach</intervention_name>
    <description>For a 12-week period, patients will be asked to access the web platform (Evolve, formerly BMIQ), review educational materials, and enter dietary information.&#xD;
From January 2019 to February 2021, participants used an earlier version of the platform, which was used in tandem with LoseIt (www.loseit.com), a meal-logging app that integrated with the platform.&#xD;
In February 2021, a platform update occurred (Evolve) where the core tenets of the program remained the same and included the dietary data entry directly on the platform.</description>
    <arm_group_label>Self-Guided Approach</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Dietitian-led Approach</intervention_name>
    <description>For a 12-week period, patients will be asked to access the web platform (Evolve, formerly BMIQ), review educational materials, and enter dietary information.&#xD;
From January 2019 to February 2021, participants used an earlier version of the platform, which was used in tandem with LoseIt (www.loseit.com), a meal-logging app that integrated with the platform.&#xD;
In February 2021, a platform update occurred (Evolve) where the core tenets of the program remained the same and included the dietary data entry directly on the platform.&#xD;
Dietitians will access the web platform and provided personalized motivational interview phone calls on a weekly basis.</description>
    <arm_group_label>Dietitian-led Approach</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  24-hour ambulatory SBP 120-160 mmHg&#xD;
&#xD;
          -  BMI â‰¥ 25 kg/m2&#xD;
&#xD;
          -  Access to a telephone&#xD;
&#xD;
          -  Access to a computer or smartphone with internet access&#xD;
&#xD;
          -  Complete dietary data entry for at least 5 out of 7 days during run-in period&#xD;
&#xD;
          -  Enter weight into the platform during run-in period&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Inability to understand English&#xD;
&#xD;
          -  Myocardial infarction, stroke, or atherosclerotic cardiovascular disease procedure&#xD;
             within last 6 months.&#xD;
&#xD;
          -  Current treatment for malignancy&#xD;
&#xD;
          -  Planned or previous bariatric surgery&#xD;
&#xD;
          -  Pregnant, breast-feeding, or planned pregnancy prior to the end of participation&#xD;
&#xD;
          -  Self-reported average consumption of &gt; 21 alcoholic beverages per week or binge&#xD;
             drinking.&#xD;
&#xD;
          -  Psychiatric hospitalization in past year&#xD;
&#xD;
          -  Current symptoms of angina&#xD;
&#xD;
          -  Planning to leave the area prior to end of the study&#xD;
&#xD;
          -  Current participation in another clinical trial&#xD;
&#xD;
          -  Principal investigator discretion (i.e. concerns about safety, compliance)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alexander Chang, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Geisinger Clinic</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Geisinger Medical Center</name>
      <address>
        <city>Danville</city>
        <state>Pennsylvania</state>
        <zip>17822</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Geisinger Wyoming Valley</name>
      <address>
        <city>Wilkes-Barre</city>
        <state>Pennsylvania</state>
        <zip>18711</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>October 5, 2018</study_first_submitted>
  <study_first_submitted_qc>October 8, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">October 9, 2018</study_first_posted>
  <last_update_submitted>July 27, 2021</last_update_submitted>
  <last_update_submitted_qc>July 27, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 28, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>lifestyle modification</keyword>
  <keyword>DASH diet</keyword>
  <keyword>weight loss</keyword>
  <keyword>exercise</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypertension</mesh_term>
    <mesh_term>Overweight</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>The study protocol, statistical analysis plan, informed consent form, analytic code, and clinical study report will be shared at the time of publication of the main trial results; these data will be deidentified. These data will be publicly available indefinitely.</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Informed Consent Form (ICF)</ipd_info_type>
    <ipd_info_type>Clinical Study Report (CSR)</ipd_info_type>
    <ipd_info_type>Analytic Code</ipd_info_type>
    <ipd_time_frame>Data will become available at the time of publication of the main trial results and will be publicly available indefinitely.</ipd_time_frame>
    <ipd_access_criteria>The deidentified IPD will be publicly available without restrictions.</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

